Tempus AI · 2 days ago
Rare Disease Account Executive - Southcoast (AL, MS, AR)
Ambry Genetics Corporation is seeking a Rare Disease Account Executive to manage the Southcoast territory, which includes Alabama, Arkansas, and Mississippi. The role involves increasing laboratory sales revenue through market penetration and promoting genetic diagnostic testing services to various medical professionals.
Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPrecision Medicine
Responsibilities
Manage a sales territory
Live in the designated territory
Manage and grow business in existing Ambry accounts
Expand menu utilization in existing accounts
Sell genetic diagnostic testing services to new customers
Negotiate and manage contracts
Introduce new testing products
Develop demand for and adoption of new assays
Develop and implement customer-specific action plans
Develop and deliver presentations
Host and assist with trade shows
Manage customer data in the company database
Achieve sales goals
Other duties as assigned
Qualification
Required
3+ years of industry experience selling laboratory services to clinicians and hospitals or medical device sales
Bachelor's Degree and/or combined years of experience required
Skilled in Microsoft Word, Excel, PowerPoint applications
Skilled using a CRM applications such as com or Microsoft CRM
Strong track record of sales success selling a broad portfolio of laboratory testing to different medical specialties
Ability to sell technically complex products
Expertise with demand creation in a large geography
Strengths in networking and relationship development
Strong oral and written communications skills
Some formal sales training experience such as SPIN Selling or PSS
Strong time and territory management skills
Possess and maintain a current, valid driver license unless agreed upon otherwise
Preferred
Bachelor's Degree is highly preferred
Experience with customer base within territory
Company
Tempus AI
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.
Funding
Current Stage
Public CompanyTotal Funding
$2.29BKey Investors
Ares ManagementGoogleBaillie Gifford
2025-06-30Post Ipo Debt· $650M
2025-02-19Post Ipo Debt· $300M
2024-06-14IPO
Recent News
Business Wire
2026-01-22
2026-01-13
Business Wire
2026-01-13
Company data provided by crunchbase